Reviva Pharmaceuticals Holdings Inc. (RVPH)
$2.52 $0.62 (29.25%) 4:37 PM 12/10/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$55.18M -
Day's Range
$2.21 - $2.80 -
Volume
2,818,196 -
52 Week Low / High
$0.60 - $5.67 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
RVPH's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 3
- Strong Buy
- 1
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $14.83
- Target Price
Company News
-
Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs — Jan 23rd, 2024
Some of the worst and most deadly diseases affect our brains. In multiple sclerosis, the immune system “causes communication problems between your brain and the rest of your body,” preventing some victims from walking.” Brain cancer is often a quick killer, while Alzheimer’s, of co...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$